| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |